Shuguang Lu

Dr. Shuguang Lu

Army Medical University, Chongqing, China
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2023 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
HLHe Liu
He Liu
ZHZhen Hu
Zhen Hu
MLMengyang Li
Mengyang Li
YYYi Yang
Yi Yang
SLShuguang Lu
Shuguang Lu
Xiancai RaoXiancai Rao
Xiancai Rao
Gram-positive (G+) bacterial infection is a great burden to both healthcare and community medical resources. As a result of the increasing prevalence of multidrug-resistant G+ bacteria such as methicillin-resistant Staphylococcusaureus (MRSA), novel antimicrobial agents must urgently be developed for the treatment of infections caused by G+ bacteria. Endolysins are bacteriophage (phage)-encoded enzymes that can specifically hydrolyze the bacterial cell wall and quickly kill bacteria. Bacterial resistance to endolysins is low. Therefore, endolysins are considered promising alternatives for solving the mounting resistance problem. In this review, endolysins derived from phages targeting G+ bacteria were classified based on their structural characteristics. The active mechanisms, efficacy, and advantages of endolysins as antibacterial drug candidates were summarized. Moreover, the remarkable potential of phage endolysins in the treatment of G+ bacterial infections was described. In addition, the safety of endolysins, challenges, and possible solutions were addressed. Notwithstanding the limitations of endolysins, the trends in development indicate that endolysin-based drugs will be approved in the near future. Overall, this review presents crucial information of the current progress involving endolysins as potential therapeutic agents, and it provides a guideline for biomaterial researchers who are devoting themselves to fighting against bacterial infections.

16 November 2024 in Advanced Materials
Verified
Journal Article
Open access
HLHe Liu
He Liu
XWXuemei Wei
Xuemei Wei
HPHuagang Peng
Huagang Peng
YYYi Yang
Yi Yang
ZHZhen Hu
Zhen Hu
Xiancai RaoXiancai Rao
Xiancai Rao
Staphylococcus aureus (S. aureus), especially methicillin‐resistant S. aureus (MRSA), causes wound infections, whose treatment remains a clinical challenge. Bacterium‐infected wounds often create acidic niches with a pH 4.5–6.5. Endolysin LysSYL, which is derived from phage SYL, shows promise as an antistaphylococcal agent. However, endolysins generally exhibit instability and possess low bioavailability in acidic microenvironments. Here, an array of self‐assembling peptides is designed, and peptide L5 is screened out based on its gel formation property and bioavailability. L5 exerted a pH‐switchable antimicrobial effect (pH 5.5) and formed biocompatible hydrogels at neutral pH (pH 7.4). The LysSYL‐loaded L5 can assemble L5@LysSYL hydrogels, increase thermal stability, and exhibit the slow‐release effect of LysSYL. Effective elimination of S. aureus is achieved by L5@LysSYL through bacterial membrane disruption and cell separation inhibition. Moreover, L5@LysSYL hydrogels exhibit great potential in promoting wound healing in a mouse wound model infected by MRSA. Furthermore, L5@LysSYL hydrogels are safe and can decrease the cytokine levels and increase the number of key factors for vessel formation, which contribute to wound healing. Overall, the self‐assembling L5@LysSYL can effectively clean MRSA and promote wound healing, which suggests its potential as a pH‐sensitive wound dressing for the management of wound infections.

1 August 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
HYHuan Yue
Huan Yue
YHYong He
Yong He
EFEnci Fan
Enci Fan
LWLin Wang
Lin Wang
SLShuguang Lu
Shuguang Lu
ZFZhi-feng Fu
Zhi-feng Fu

15 April 2021 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
YLYifei Lu
Yifei Lu
YWYingran Wang
Yingran Wang
JWJing Wang
Jing Wang
YZYan Zhao
Yan Zhao
QZQiu Zhong
Qiu Zhong
SLShuguang Lu
Shuguang Lu
As a potential antibacterial agent, endolysin can directly lyse Gram-positive bacteria from the outside and does not lead to drug resistance. Considering that XN108 is the first reported methicillin-resistant Staphylococcus aureus (MRSA) strain in mainland China with a vancomycin MIC that exceeds 8 µg mL-1, we conducted a systematic study on its phage-encoded endolysin LysP108. Standard plate counting method revealed that LysP108 could lyse S. aureus and Pseudomonas aeruginosa with damaged outer membrane, resulting in a significant reduction in the number of live bacteria. Scanning electron microscopy results showed that S. aureus cells could be lysed directly from the outside by LysP108. Live/dead bacteria staining results indicated that LysP108 possessed strong bactericidal ability, with an anti-bacterial rate of approximately 90%. Crystal violet staining results implied that LysP108 could also inhibit and destroy bacterial biofilms. In vivo animal experiments suggested that the area of subcutaneous abscess of mice infected with MRSA was significantly reduced after the combined injection of LysP108 and vancomycin in comparison with monotherapy. The synergistic antibacterial effects of LysP108 and vancomycin were confirmed. Therefore, the present data strongly support the idea that endolysin LysP108 exhibits promising antibacterial potential to be used as a candidate for the treatment of infections caused by MRSA.

30 January 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
YHYong He
Yong He
MWMengyao Wang
Mengyao Wang
EFEnci Fan
Enci Fan
HOHui Ouyang
Hui Ouyang
HYHuan Yue
Huan Yue
ZFZhi-feng Fu
Zhi-feng Fu

1 June 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
HYHonglin Yang
Honglin Yang
YWYingran Wang
Yingran Wang
SLShengyin Liu
Shengyin Liu
HOHui Ouyang
Hui Ouyang
SLShuguang Lu
Shuguang Lu
ZFZhi-feng Fu
Zhi-feng Fu